Sunrise

company

About

We make a 3-gram sensor to diagnose sleep with gold standard quality.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
€6.50M
Industries
Health Care,Lifestyle,Medical Device,Wellness
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.

We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate as in-lab sleep studies, at a fraction of the cost.

Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.

Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€6.50M
Sunrise has raised a total of €6.50M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2021 Seed €6.50M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Sunrise is funded by 2 investors. Fonds Vives II (University of Louvain, UCL) and Namur Invest are the most recent investors.
Investor Name Lead Investor Funding Round
Fonds Vives II (University of Louvain, UCL) — Seed
Namur Invest — Seed